Predicting Response to Atomoxetine and Methylphenidate
ID Number 03-0612
Principal Investigator(s)Jeffrey Newcorn
Department(s) or Division(s)
Psychiatry
Description
The purpose of this study is three-fold. First, to compare the efficacy of four to five weeks of treatment with methylphenidate (Concerta™) and atomoxetine (Strattera™) on ADHD symptoms and associated functional impairment. Second, to evaluate differences in adverse effects and palatability between the two treatments. Third, to evaluate clinical and pharmacogenetic moderators of response to the two treatments.
Contact Information
Beth K. Krone, CRC
(212) 659-8833
beth.krone@mssm.edu
Recruiting Patients: Yes